Pulse Biosciences, Inc. (PLSE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 925.34M |
| Enterprise Value | 852.13M |
| P/E Ratio | -45.93 |
| PEG Ratio | 8.99 |
| Price/Sales Ratio | 2,713.53 |
| Price/Book Ratio | 21.6 |
| Enterprise/Revenue | 2,693.21 |
| Enterprise/EBITDA | -48.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -56.04 |
| Operating Margin | -58.21 |
| Return On Assets | -0.42 |
| Return On Equity | -0.78 |
| Revenue | 350,000 |
| Revenue/Share | 0.02 |
| Gross Profit | -1.26M |
| EBITDA | -71.71M |
| Net Income | -72.78M |
| Diluted EPS | -1.08 |
| Total Cash | 189.19M |
| Total Cash/Share | 2.63 |
| Total Debt | 6.36M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 14.35 |
| Book Value Per Share | 2.55 |
| 52-Week Change | 259.79 |
| 52-Week High | 58.94 |
| 52-Week Low | 12.56 |
| Moving Average 50 Days | 51.76 |
| Moving Average 200 Days | 32.55 |
| Average Volume | 506,926 |
| Shares Outstanding | 73.55M |
| % Held by Institutions | 15.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |